Patents by Inventor M. Menon

M. Menon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115650
    Abstract: The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 11, 2023
    Publication date: April 11, 2024
    Applicant: ABBVIE INC.
    Inventors: Walid M. Awni, Barry M. Bernstein, Andrew L. Campbell, Sandeep Dutta, Chih-Wei Lin, Wei Liu, Rajeev M. Menon, Thomas J. Podsadecki, Tianli Wang, Sven Mensing
  • Publication number: 20240057374
    Abstract: An OLED is disclosed that includes an enhancement layer having optically active metamaterials, or hyperbolic metamaterials, which transfer radiative energy from the organic emissive material to a non-radiative mode, wherein the enhancement layer is disposed over the organic emissive layer opposite from the first electrode, and is positioned no more than a threshold distance away from the organic emissive layer, wherein the organic emissive material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer, and the threshold distance is where the total non-radiative decay rate constant is equal to the total radiative decay rate constant; and an outcoupling layer disposed over the enhancement layer, wherein the outcoupling layer scatters radiative energy from the enhancement layer to free space.
    Type: Application
    Filed: October 19, 2023
    Publication date: February 15, 2024
    Inventors: Nicholas J. Thompson, Marc A. Baldo, Michael S. Weaver, Vinod M. Menon
  • Patent number: 11860925
    Abstract: In some examples, human centered computing based digital persona generation may include generating, for a digital persona that is to be generated for a target person, synthetic video files and synthetic audio files that are combined to generate synthetic media files. The digital persona may be generated based on a synthetic media file. An inquiry may be received from a user of the generated digital persona. Another synthetic media file may be used by the digital persona to respond to the inquiry. A real-time emotion of the user may be analyzed based on a text sentiment associated with the inquiry, and a voice sentiment and a facial expression associated with the user. Based on the real-time emotion of the user, a further synthetic media file may be utilized by the digital persona to continue or modify a conversation between the generated digital persona and the user.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: January 2, 2024
    Assignee: ACCENTURE GLOBAL SOLUTIONS LIMITED
    Inventors: Nisha Ramachandra, Manish Ahuja, Raghotham M Rao, Neville Dubash, Sanjay Podder, Rekha M. Menon
  • Publication number: 20230413596
    Abstract: Embodiments of the disclosed subject matter provide a device including one or more organic layers that include an emissive layer, a first electrode layer disposed over the one or more organic layers, a plurality of nanostructures formed as part of the first electrode layer, a substrate, a second electrode layer, where the second electrode layer is disposed on the substrate, the one or more organic layers are disposed on the second electrode layer, and the first electrode layer including the plurality of nanostructures is disposed on the one or more organic layers and within the predetermined threshold distance of the emissive layer.
    Type: Application
    Filed: August 31, 2023
    Publication date: December 21, 2023
    Inventors: Vinod M. MENON, Michael FUSELLA, Nicholas J. THOMPSON
  • Publication number: 20230413590
    Abstract: Embodiments of the disclosed subject matter provide a device that may include an organic light emitting device (OLED) having a substrate, a first electrode disposed over the substrate, a second electrode disposed over the first electrode, and an organic emissive layer having a first surface positioned over a second surface is disposed between the first electrode and the second electrode. A nanoparticle layer may be disposed over the organic emissive layer and has a first surface that is positioned over a second surface. The nanoparticle layer may include a first plurality of nanoparticles comprising a dielectric material, and a surrounding medium. A distance from the second surface of the nanoparticle layer to the first surface of the organic emissive layer may be not more than 50 nm, and there may be a difference of at least 1.0 between a refractive index of the dielectric material and the surrounding medium.
    Type: Application
    Filed: May 31, 2023
    Publication date: December 21, 2023
    Inventors: Haridas MUNDOOR, Nicholas J. THOMPSON, Vinod M. MENON
  • Publication number: 20230385268
    Abstract: The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 11, 2023
    Publication date: November 30, 2023
    Applicant: AbbVie Inc.
    Inventors: Walid M. Awni, Barry M. Bernstein, Andrew Campbell, Sandeep Dutta, Chih-Wei Lin, Wei Liu, Rajeev M. Menon, Sven Mensing, Thomas J. Podsadecki, Tianli Wang
  • Patent number: 11832474
    Abstract: An OLED is disclosed that includes an enhancement layer having optically active metamaterials, or hyperbolic metamaterials, which transfer radiative energy from the organic emissive material to a non-radiative mode, wherein the enhancement layer is disposed over the organic emissive layer opposite from the first electrode, and is positioned no more than a threshold distance away from the organic emissive layer, wherein the organic emissive material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer, and the threshold distance is where the total non-radiative decay rate constant is equal to the total radiative decay rate constant; and an outcoupling layer disposed over the enhancement layer, wherein the outcoupling layer scatters radiative energy from the enhancement layer to free space.
    Type: Grant
    Filed: December 27, 2022
    Date of Patent: November 28, 2023
    Assignee: Universal Display Corporation
    Inventors: Nicholas J. Thompson, Marc A. Baldo, Michael S. Weaver, Vinod M. Menon
  • Patent number: 11793015
    Abstract: Embodiments of the disclosed subject matter provide a device including one or more organic layers that include an emissive layer, a first electrode layer disposed over the one or more organic layers, a plurality of nanostructures formed as part of the first electrode layer, a substrate, a second electrode layer, where the second electrode layer is disposed on the substrate, the one or more organic layers are disposed on the second electrode layer, and the first electrode layer including the plurality of nanostructures is disposed on the one or more organic layers and within the predetermined threshold distance of the emissive layer.
    Type: Grant
    Filed: December 29, 2021
    Date of Patent: October 17, 2023
    Assignee: Universal Display Corporation
    Inventors: Vinod M. Menon, Michael Fusella, Nicholas J. Thompson
  • Patent number: 11709202
    Abstract: Existing multi-wire debugging protocols, such as 4-wire JTAG, 2-wire cJTAG, or ARM SWD, are run through a serial wireless link by providing the debugger and the target device with hardware interfaces that include UARTs and conversion bridges. The debugger interface serializes outgoing control signals and de-serializes returning data. The target interface de-serializes incoming control signals and serializes outgoing data. The actions of the interfaces are transparent to the inner workings of the devices, allowing re-use of existing debugging software. Compression, signal combining, and other optional enhancements increase debugging speed and flexibility while wirelessly accessing target devices that may be too small, too difficult to reach, or too seal-dependent for a wired connection.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: July 25, 2023
    Assignee: Intel Corporation
    Inventors: Sankaran M. Menon, Bradley H. Smith, Jinshi Huang, Rolf H. Kuehnis
  • Patent number: 11698412
    Abstract: Techniques and mechanisms to exchange test, debug or trace (TDT) information via a general purpose input/output (I/O) interface. In an embodiment, an I/O interface of a device is coupled to an external TDT unit, wherein the I/O interface is compatible with an interconnect standard that supports communication of data other than any test information, debug information or trace information. One or more circuit components reside on the device or are otherwise coupled to the external TDT unit via the I/O interface. Information exchanged via the I/O interface is generated by, or results in, the performance of one or more TDT operations to evaluate the one or more circuit components. In another embodiment, the glue logic of the device interfaces the I/O interface with a test access point that is coupled between the one or more circuit components and the I/O interface.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: July 11, 2023
    Assignee: Intel Corporation
    Inventors: Rolf H. Kuehnis, Sankaran M. Menon, Patrik Eder
  • Patent number: 11686780
    Abstract: Described is an apparatus which comprises: a first voltage regulator (VR) having a reference input node; and a first multiplexer to provide a reference voltage to the reference input node and operable to select one of at least two different reference voltages as the reference voltage.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: June 27, 2023
    Assignee: Intel Corporation
    Inventors: Sankaran M. Menon, Vasudev Bibikar, P. Reddy Sahajananda, Sunghyun Koh, Naveendran Balasingam
  • Publication number: 20230157058
    Abstract: High-efficiency plasmonic OLED displays are provided that use the design of the plasmonic device to overcome some of the shortcomings of conventional display panels. Control of the Stokes parameters of the emitted light and/or modification of the ambient light incident on the device relative to the emitted light is used to maximize the amount of visible light emitted by the display.
    Type: Application
    Filed: November 2, 2022
    Publication date: May 18, 2023
    Inventors: Haridas MUNDOOR, Nicholas J. THOMPSON, Vinod M MENON
  • Publication number: 20230141141
    Abstract: An OLED is disclosed that includes an enhancement layer having optically active metamaterials, or hyperbolic metamaterials, which transfer radiative energy from the organic emissive material to a non-radiative mode, wherein the enhancement layer is disposed over the organic emissive layer opposite from the first electrode, and is positioned no more than a threshold distance away from the organic emissive layer, wherein the organic emissive material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer, and the threshold distance is where the total non-radiative decay rate constant is equal to the total radiative decay rate constant; and an outcoupling layer disposed over the enhancement layer, wherein the outcoupling layer scatters radiative energy from the enhancement layer to free space.
    Type: Application
    Filed: December 27, 2022
    Publication date: May 11, 2023
    Inventors: Nicholas J. Thompson, Marc A. Baldo, Michael S. Weaver, Vinod M. Menon
  • Patent number: 11569481
    Abstract: An OLED is disclosed that includes an enhancement layer having optically active metamaterials, or hyperbolic metamaterials, which transfer radiative energy from the organic emissive material to a non-radiative mode, wherein the enhancement layer is disposed over the organic emissive layer opposite from the first electrode, and is positioned no more than a threshold distance away from the organic emissive layer, wherein the organic emissive material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer, and the threshold distance is where the total non-radiative decay rate constant is equal to the total radiative decay rate constant; and an outcoupling layer disposed over the enhancement layer, wherein the outcoupling layer scatters radiative energy from the enhancement layer to free space.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: January 31, 2023
    Assignee: Universal Display Corporation
    Inventors: Nicholas J. Thompson, Marc A. Baldo, Michael S. Weaver, Vinod M. Menon
  • Patent number: 11484534
    Abstract: The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: November 1, 2022
    Assignee: AbbVie Inc.
    Inventors: Walid M. Awni, Barry M. Bernstein, Andrew L. Campbell, Sandeep Dutta, Chih-Wei Lin, Wei Liu, Rajeev M. Menon, Sven Mensing, Thomas J. Podsadecki, Tianli Wang
  • Publication number: 20220288153
    Abstract: The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of interferon, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 24, 2021
    Publication date: September 15, 2022
    Applicant: AbbVie Inc.
    Inventors: Walid M. Awni, Barry M. Bernstein, Andrew L. Campbell, Sandeep Dutta, Chih-Wei Lin, Wei Liu, Rajeev M. Menon, Thomas J. Podsadecki, Tianli Wang, Sven Mensing
  • Publication number: 20220149315
    Abstract: Embodiments of the disclosed subject matter provide a device including one or more organic layers that include an emissive layer, a first electrode layer disposed over the one or more organic layers, a plurality of nanostructures formed as part of the first electrode layer, a substrate, a second electrode layer, where the second electrode layer is disposed on the substrate, the one or more organic layers are disposed on the second electrode layer, and the first electrode layer including the plurality of nanostructures is disposed on the one or more organic layers and within the predetermined threshold distance of the emissive layer.
    Type: Application
    Filed: December 29, 2021
    Publication date: May 12, 2022
    Inventors: Vinod M. MENON, Michael FUSELLA, Nicholas J. THOMPSON
  • Publication number: 20220082617
    Abstract: Techniques and mechanisms to exchange test, debug or trace (TDT) information via a general purpose input/output (I/O) interface. In an embodiment, an I/O interface of a device is coupled to an external TDT unit, wherein the I/O interface is compatible with an interconnect standard that supports communication of data other than any test information, debug information or trace information. One or more circuit components reside on the device or are otherwise coupled to the external TDT unit via the I/O interface. Information exchanged via the I/O interface is generated by, or results in, the performance of one or more TDT operations to evaluate the one or more circuit components. In another embodiment, the glue logic of the device interfaces the I/O interface with a test access point that is coupled between the one or more circuit components and the I/O interface.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 17, 2022
    Applicant: Intel Corporation
    Inventors: Rolf H. Kuehnis, Sankaran M. Menon, Patrik Eder
  • Patent number: 11245086
    Abstract: Embodiments of the disclosed subject matter provide a device including one or more organic layers that include an emissive layer, a first electrode layer disposed over the one or more organic layers, a plurality of nanostructures formed as part of the first electrode layer, a substrate, a second electrode layer, where the second electrode layer is disposed on the substrate, the one or more organic layers are disposed on the second electrode layer, and the first electrode layer including the plurality of nanostructures is disposed on the one or more organic layers and within the predetermined threshold distance of the emissive layer.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: February 8, 2022
    Assignee: Universal Display Corporation
    Inventors: Vinod M Menon, Michael Fusella, Nicholas J. Thompson
  • Patent number: 11193973
    Abstract: Techniques and mechanisms to exchange test, debug or trace (TDT) information via a general purpose input/output (I/O) interface. In an embodiment, an I/O interface of a device is coupled to an external TDT unit, wherein the I/O interface is compatible with an interconnect standard that supports communication of data other than any test information, debug information or trace information. One or more circuit components reside on the device or are otherwise coupled to the external TDT unit via the I/O interface. Information exchanged via the I/O interface is generated by, or results in, the performance of one or more TDT operations to evaluate the one or more circuit components. In another embodiment, the glue logic of the device interfaces the I/O interface with a test access point that is coupled between the one or more circuit components and the I/O interface.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: December 7, 2021
    Assignee: Intel Corporation
    Inventors: Rolf H. Kuehnis, Sankaran M. Menon, Patrik Eder